Filing Details

Accession Number:
0001341004-18-000596
Form Type:
13G Filing
Publication Date:
2018-10-26 16:57:51
Filed By:
Point State Capital
Company:
Outlook Therapeutics Inc.
Filing Date:
2018-10-26
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
PointState Fund 0 0 0 0 0 0%
PointState Holdings 0 1,353,000 0 1,353,000 1,353,000 1.8%
PointState Capital 0 1,353,000 0 1,353,000 1,353,000 1.8%
PointState Capital GP 0 1,353,000 0 1,353,000 1,353,000 1.8%
Zachary J. Schreiber 0 1,353,000 0 1,353,000 1,353,000 1.8%
Filing
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
 
(Amendment No. 2)*
 
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
Oncobiologics, Inc.
(Name of Issuer)
 
Common Stock, par value $0.01
(Title of Class of Securities)
68235M105
(CUSIP Number)
 
October 26, 2018
(Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
 
Rule 13d-1(b)
 
 
Rule 13d-1(c)
 
 
Rule 13d-1(d)
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosure provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of the section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 




CUSIP No.
68235M105
 

 
1
NAME OF REPORTING PERSON
 
PointState Fund LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)       
(b)       
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
0
6
SHARED VOTING POWER
0
7
SOLE DISPOSITIVE POWER
0
8
SHARED DISPOSITIVE POWER
0
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
12
TYPE OF REPORTING PERSON
PN
 
 
 
 





CUSIP No.
68235M105
 

 
1
NAME OF REPORTING PERSON
 
PointState Holdings LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)       
(b)       
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
0
6
SHARED VOTING POWER
1,353,000
7
SOLE DISPOSITIVE POWER
0
8
SHARED DISPOSITIVE POWER
1,353,000
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,353,000
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.8%
12
TYPE OF REPORTING PERSON
OO
 
 
 
 
 




CUSIP No.
68235M105
 

 
1
NAME OF REPORTING PERSON
 
PointState Capital LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)       
(b)       
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
0
6
SHARED VOTING POWER
1,353,000
7
SOLE DISPOSITIVE POWER
0
8
SHARED DISPOSITIVE POWER
1,353,000
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,353,000
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.8%
12
TYPE OF REPORTING PERSON
IA, PN
 
 
 
 
  




CUSIP No.
68235M105
 
 

1
NAME OF REPORTING PERSON
 
PointState Capital GP LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)       
(b)       
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
0
6
SHARED VOTING POWER
1,353,000
7
SOLE DISPOSITIVE POWER
0
8
SHARED DISPOSITIVE POWER
1,353,000
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,353,000
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.8%
12
TYPE OF REPORTING PERSON
OO
 
 
 
 
 




CUSIP No.
68235M105
 
 

1
NAME OF REPORTING PERSON
 
Zachary J. Schreiber
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)       
(b)       
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5
SOLE VOTING POWER
0
6
SHARED VOTING POWER
1,353,000
7
SOLE DISPOSITIVE POWER
0
8
SHARED DISPOSITIVE POWER
1,353,000
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,353,000
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.8%
12
TYPE OF REPORTING PERSON
IN
 
 
 
 
 

 


 
Item 1(a)
Name of Issuer
     
   
The name of the issuer is Oncobiologics, Inc. (the “Company”).
 
 
 
Item 1(b)
Address of Issuer’s Principal Executive Offices
     
   
The Company’s principal executive offices are located at:
7 Clarke Drive, Cranbury, New Jersey 08512.
 
 
 
Item 2(a)
Name of Person Filing
     
   
This statement is filed by:
 
 
(i)
PointState Fund LP, a Delaware limited partnership (“PointState Fund”);
 
 
(ii)
PointState Holdings LLC, a Delaware limited liability company (“PointState Holdings”), which serves as the general partner to SteelMill Master Fund, LP, a Cayman Islands exempted limited partnership (“SteelMill”) and PointState Fund;
 
 
(iii)
PointState Capital LP, a Delaware limited partnership (“PointState”), which serves as the investment manager to SteelMill and PointState Fund;
 
 
(iv)
PointState Capital GP LLC, a Delaware limited liability company (“PointState GP”), which serves as the general partner to PointState; and
 
 
(v)
Zachary J. Schreiber (“Mr. Schreiber”), who serves as managing member of PointState Holdings and PointState GP.
     
 
PointState Fund, PointState Holdings, PointState, PointState GP and Mr. Schreiber are hereinafter sometimes collectively referred to as the “Reporting Persons.” Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.
 
The Reporting Persons are filing this statement jointly with respect to the same securities as contemplated by Rule 13d-1(k)(1), not as members of a group.
 
 
 
Item 2(b)
Address of Principal Business Office or, if None, Residence
     
   
The address of the business office of each of the Reporting Persons is care of PointState Capital LP, 40 West 57th Street, 25th Floor, New York, NY 10019.
 
 
 
7
 


 
Item 2(c)
Citizenship
     
   
PointState Fund, PointState Holdings, PointState, and PointState GP are organized under the laws of Delaware. Mr. Schreiber is a citizen of the United States of America.
 
 
 
Item 2(d)
Title of Class of Securities
     
   
Common Stock, par value $0.01 per share (“Common Shares”).
 
 
 
Item 2(e)
CUSIP No.
     
   
68235M105
 
 
 
Item 3.
If This Statement Is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
     
   
N/A
 
 
 
Item 4.
Ownership
     
   
SteelMill is the direct holder of warrants that may be exercised to purchase 1,353,000 Common Shares.
 
The information in Items 5 through 9 and Item 11 on the cover pages to this Schedule 13G is hereby incorporated by reference.
 
All percentages of Common Shares outstanding contained herein assume that 72,198,468 Common Shares are outstanding as of August 10, 2018, as disclosed on the Company’s Form 10-Q, filed with the Securities and Exchange Commission on August 14, 2018.
 

 
Item 5.
Ownership of Five Percent or Less of a Class
     
   
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X].
 
 
 
Item 6.
Ownership of More Than Five Percent on Behalf of Another Person
     
   
N/A
 
 
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
     
   
The information in Items 2 and 4 is hereby incorporated by reference.
 
 
 
Item 8.
Identification and Classification of Members of the Group
     
   
N/A
 

 
 
8
 
 


 
Item 9.
Notice of Dissolution of Group
     
   
N/A
 
 
 
Item 10.
Certification
     
   
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
 

 
 
9
 
 
 


SIGNATURES
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Dated: October 26, 2018
 
 
POINTSTATE FUND LP
 
 
 
By: PointState Capital LP, as its investment manager
 
By: PointState Holdings LLC, as its general partner
 
 
 
By:
/s/ Zachary J. Schreiber
 
 
Name:  Zachary J. Schreiber
 
 
 
POINTSTATE HOLDINGS LLC
 
 
 
By:
/s/ Zachary J. Schreiber
 
 
Name:  Zachary J. Schreiber
 
 
Title:  Managing Member
 
 
 
POINTSTATE CAPITAL LP
 
 
 
By:  
/s/ Zachary J. Schreiber
 
 
Name:  Zachary J. Schreiber
 
 
Title:  Managing Member
 
 
 
POINTSTATE CAPITAL GP LLC
 
 
 
By:
/s/ Zachary J. Schreiber
 
 
Name:  Zachary J. Schreiber
 
 
Title:  Managing Member
 
 
 
By:
/s/ Zachary J. Schreiber
 
 
Name:  Zachary J. Schreiber
 

 
10